We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Laboratory Testing Consolidated into Fewer More Appropriate Systems

By LabMedica International staff writers
Posted on 15 Sep 2009
Print article
Laboratory testing is being consolidated in fewer more apt systems. For example, test panels for anemia, cardiac disease, thyroid disorders, therapeutic drug monitoring, protein testing, drugs-of-abuse testing, and routine and specialty chemistry testing are being offered in one system.

An expanded portfolio of Dimension Vista systems meets the needs of all sizes of clinical laboratories. Dimension Vista 500 Intelligent Lab System, the latest addition to the family of ultra-integrated chemistry and immunochemistry systems, was recently introduced and has a test menu of more than 115 assays. The new system offers improved quality and reduced time to produce patient test results. The expanded portfolio of Dimension Vista systems meets the needs of all sizes of clinical laboratories.

The Dimension Vista 500 Intelligent Lab System has a throughput of up to 1,000 patient tests per hour. The Dimension Vista 1000T Intelligent Lab System can also be achieved by seamlessly adjoining two Dimension Vista 500 Systems. This doubles the throughput capacity to up to 2,000 tests per hour, and provides mirror back-up capabilities and increased walk-away time for laboratory personnel.

As with other Dimension Vista systems, four advanced detection technologies including photometry, nephelometry, V-Lyte electrolyte, and Loci advanced chemiluminescence are used on the systems, resulting in a broad test menu. The Loci technology allows customers access to fast, sensitive immunoassay testing and fast analytical turnaround time of 10 minutes for critical cardiac tests such as high-sensitivity Troponin I.

"We are bringing next-generation technology to mid-volume laboratory customers by leveraging the success of the Dimension Vista 1500 System, a similar integrated diagnostic testing solution for high-volume laboratories that was introduced by Siemens in 2007," said Donal Quinn, CEO at Siemens Healthcare Diagnostics (Erlangen, Germany). "The mid-volume Dimension Vista 500 System represents another major step toward improving the quality, efficiency, and time to produce patient test results by consolidating testing onto fewer, more intelligent systems."

Siemens met the U.S. Food and Drug Administration's (FDA; Silver Spring, MD, USA) regulatory requirements to sell the Dimension Vista 500 and 1000T Intelligent Lab Systems, and both instruments are CE marked. The portfolio of Dimension Vista systems also addresses the need for standardization in large hospital networks with remote or satellite laboratories, by offering standardized patient test results and operating features.

Related Links:

Siemens Healthcare Diagnostics
U.S. Food and Drug Administration



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Automated Blood Typing System
IH-500 NEXT
New
Hepatitis B Virus Test
HBs Ab – ELISA
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.